Prevalence and Characteristics of Painful Diabetic Neuropathy in a Large Community-Based Diabetic Population in the U.K.
Open accessThe DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To assess, in the general diabetic population, 1) the prevalence of painful neuropathic symptoms; 2) the relationship between symptoms and clinical severity of neuropathy; and 3) the role of diabetes type, sex, and ethnicity in painful neuropathy. RESEARCH DESIGN AND METHODS: Observational study of a large cohort of diabetic patients receiving community-based health care in northwest England (n = 15,692). Painful diabetic neuropathy (PDN) was assessed using neuropathy symptom score (NSS) and neuropathy disability score (NDS). RESULTS: Prevalence of painful symptoms (NSS ≥5) and PDN (NSS ≥5 and NDS ≥3) was 34 and 21%, respectively. Painful symptoms occurred in 26% of patients without neuropathy (NDS ≤2) and 60% of patients with severe neuropathy (NDS >8). Adjusted risk of painful neuropathic symptoms in type 2 diabetes was double that of type 1 diabetes (odds ratio [OR] = 2.1 [95% CI 1.7–2.4], P < 0.001) and not affected by severity of neuropathy, insulin use, foot deformities, smoking, or alcohol. Women had 50% increased adjusted risk of painful symptoms compared with men (OR = 1.5 [1.4–1.6], P < 0.0001). Despite less neuropathy in South Asians (14%) than Europeans (22%) and African Caribbeans (21%) (P < 0.0001), painful symptoms were greater in South Asians (38 vs. 34 vs. 32%, P < 0.0001). South Asians without neuropathy maintained a 50% increased risk of painful neuropathy symptoms compared with other ethnic groups (P < 0.0001). CONCLUSIONS: One-third of all community-based diabetic patients have painful neuropathy symptoms, regardless of their neuropathic deficit. PDN was more prevalent in patients with type 2 diabetes, women, and people of South Asian origin. This highlights a significant morbidity due to painful neuropathy and identifies key groups who warrant screening for PDN.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Diabetic peripheral polyneuropathy (also known as diabetic neuropathy) affects 50% of patients with diabetes [3–5]”
From A Consideration of the Psychological Aspects to Managing Patients with Painful Diabetic Neuropathy: An Insight into Pain Management Services at a Tertiary Centre in the UK (2021) · cites this paper as [4]
Experimental — accuracy not yet measuredIn the citing paper
“with previous studies suggesting that it affects 21% of patients with neuropathy (23)”
From Development of a Core Outcome Set for Studies Assessing Interventions for Diabetes-Related Foot Ulceration (2024) · cites this paper as [23]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The global burden of diabetic foot disease
Boulton, A. J., Vileikyte, L., Ragnarson-Tennvall, G., & Apelqvist, J. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67698-2 · Cited by 2,566
Self-citationYoung, M. J., Boulton, A. J. M., Macleod, A. F., Williams, D. R. R., & Sonksen, P. H. (1993) · Diabetologia · doi:10.1007/bf00400697 · Cited by 1,502
Self-citationAbbott, C. A., Carrington, A. L., Ashe, H., Bath, S., Every, L. C., Griffiths, J., Hann, A. W., Hussein, A., Jackson, N., Johnson, K. E., et al. (2002) · Diabetic Medicine · doi:10.1046/j.1464-5491.2002.00698.x · Cited by 1,056
Self-citationThe Prevalence, Severity, and Impact of Painful Diabetic Peripheral Neuropathy in Type 2 Diabetes
Davies, M., Brophy, S., Williams, R., & Taylor, A. (2006) · Diabetes Care · doi:10.2337/dc05-2228 · Cited by 746
Tesfaye, S., Stevens, L. K., Stephenson, J. M., Fuller, J. H., Plater, M., Ionescu-Tirgoviste, C., Nuber, A., Pozza, G., & Ward, J. D. (1996) · Diabetologia · doi:10.1007/s001250050586 · Cited by 695
Bril, V., England, J., Franklin, G. M., Backonja, M., Cohen, J., Del Toro, D., Feldman, E., Iverson, D. J., Perkins, B., Russell, J. W., et al. (2011) · Neurology · doi:10.1212/wnl.0b013e3182166ebe · Cited by 634
Daousi, C., MacFarlane, I. A., Woodward, A., Nurmikko, T. J., Bundred, P. E., & Benbow, S. J. (2004) · Diabetic Medicine · doi:10.1111/j.1464-5491.2004.01271.x · Cited by 454
Foot complications in Type 2 diabetes: an Australian population‐based study
Tapp, R. J., Shaw, J. E., De Courten, M. P., Dunstan, D. W., Welborn, T. A., & Zimmet, P. Z. (2003) · Diabetic Medicine · doi:10.1046/j.1464-5491.2003.00881.x · Cited by 193
Cabezas-Cerrato, J. (1998) · Diabetologia · doi:10.1007/s001250051063 · Cited by 192
Abbott, C. A., Garrow, A. P., Carrington, A. L., Morris, J., Van Ross, E. R., & Boulton, A. J. (2005) · Diabetes Care · doi:10.2337/diacare.28.8.1869 · Cited by 171
Self-citation
Cited by
Items 101–200 of 870
Cytokine Signaling in Diabetic Neuropathy: A Key Player in Peripheral Nerve Damage
Nashtahosseini, Z., Eslami, M., Paraandavaji, E., Haraj, A., Dowlat, B. F., Hosseinzadeh, E., Oksenych, V., & Naderian, R. (2025) · Biomedicines · doi:10.3390/biomedicines13030589 · Cited by 94
“Painful diabetic peripheral neuropathy (pDPN) is a condition that significantly impacts both health-related quality of life and general functionality, affecting around 20% of patients [5].”
Eldabe, S. S., Espinet, A. J., Wåhlstedt, A., Kang, P., Liem, L., Patel, N. K., Vesper, J., Kimber, A., Cusack, W. F., & Kramer, J. M. (2018) · Neuromodulation Technology at the Neural Interface · doi:10.1111/ner.12767 · Cited by 74
Bansal, D. (2013) · Pain Physician · doi:10.36076/ppj.2013/16/e705 · Cited by 73
A Review on Cellular and Molecular Mechanisms Linked to the Development of Diabetes Complications
Babel, R. A., & Dandekar, M. P. (2020) · Current Diabetes Reviews · doi:10.2174/1573399816666201103143818 · Cited by 97
Li, C., Wang, W., Ji, Q., Ran, X., Kuang, H., Yu, X., Fang, H., Yang, J., Liu, J., Xue, Y., et al. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.110602 · Cited by 91
Lipids: A Suitable Therapeutic Target in Diabetic Neuropathy?
Pérez-Matos, M. C., Alvarez, M. C. M., & Mendivil, C. O. (2017) · Journal of Diabetes Research · doi:10.1155/2017/6943851 · Cited by 88
Peripheral Glial Cells in the Development of Diabetic Neuropathy
Gonçalves, N. P., Vægter, C. B., & Pallesen, L. T. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00268 · Cited by 70
Corneal Confocal Microscopy: A Biomarker for Diabetic Peripheral Neuropathy
Petropoulos, I. N., Ponirakis, G., Ferdousi, M., Azmi, S., Kalteniece, A., Khan, A., Gad, H., Bashir, B., Marshall, A. G., Boulton, A. J. M., et al. (2021) · Clinical Therapeutics · doi:10.1016/j.clinthera.2021.04.003 · Cited by 83
Self-citationBurning through the pain: treatments for diabetic neuropathy
Javed, S., Alam, U., & Malik, R. A. (2015) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12535 · Cited by 78
“A third of people with diabetes report pain as a symptom, regardless of the neuropathic deficit [8].”
BackgroundSelf-citationDidangelos, T., Karlafti, E., Kotzakioulafi, E., Kontoninas, Z., Margaritidis, C., Giannoulaki, P., & Kantartzis, K. (2020) · Nutrients · doi:10.3390/nu12113254 · Cited by 76
“Due to the painful symptoms and resulting disabilities, DN strongly affects quality of life [4,9,10].”
BackgroundLu, X., & Zhao, C. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-981-15-1792-1_7 · Cited by 91
Yu, S., Chen, Y., Hou, X., Xu, D., Che, K., Li, C., Yan, S., Wang, Y., & Wang, B. (2015) · Molecular Neurobiology · doi:10.1007/s12035-014-9075-0 · Cited by 67
Kalteniece, A., Ferdousi, M., Azmi, S., Mubita, W., Marshall, A. G., Lauria, G., Faber, C. G., Soran, H., & Malik, R. A. (2020) · Scientific Reports · doi:10.1038/s41598-020-60422-7 · Cited by 72
Self-citationIn Vitro and In Vivo Effects of Flavonoids on Peripheral Neuropathic Pain
Basu, P., & Basu, A. (2020) · Molecules · doi:10.3390/molecules25051171 · Cited by 73
“The prevalence of neuropathic pain has increased 60% in severe clinical neuropathic conditions [7].”
BackgroundBotulinum Neurotoxin for the Treatment of Neuropathic Pain
Egeo, G., Fofi, L., & Barbanti, P. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.00716 · Cited by 75
Abbas, Z. G., & Boulton, A. J. M. (2021) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2021.109155 · Cited by 93
Self-citationCurrent Strategies for the Management of Painful Diabetic Neuropathy
Staudt, M. D., Prabhala, T., Sheldon, B. L., Quaranta, N., Zakher, M., Bhullar, R. K., Pilitsis, J. G., & Argoff, C. E. (2020) · Journal of Diabetes Science and Technology · doi:10.1177/1932296820951829 · Cited by 99
Guidelines in the management of diabetic nerve pain clinical utility of pregabalin
Vinik, A., & Casellini (2013) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s24825 · Cited by 63
Wang, X., Li, Q., Han, X., Gong, M., Yu, Z. H., & Xu, B. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.655591 · Cited by 77
Disparities in diabetes mellitus among Caribbean populations: a scoping review
Bennett, N. R., Francis, D., Ferguson, T. S., Hennis, A. J. M., Wilks, R., Harris, E. N., MacLeish, M. M., & Sullivan, L. W. (2015) · International Journal for Equity in Health · doi:10.1186/s12939-015-0149-z · Cited by 72
“Twelve studies investigated disparities in micro-vascular and macro-vascular complications among persons with diabetes [13,14,19,24,27,33,34,37,39,40,45,46,48].”
BackgroundYang, J., Yang, X., Zhao, D., Wang, X., Wei, W., & Yuan, H. (2021) · Journal of Diabetes Investigation · doi:10.1111/jdi.13394 · Cited by 62
The Treatment of Painful Diabetic Neuropathy
SLOAN, G. P., Alam, U., Selvarajah, D., & Tesfaye, S. H. (2021) · Current Diabetes Reviews · doi:10.2174/1573399817666210707112413 · Cited by 71
Cheng, K.-F., Wang, H., Chuang, Y. ‐., Chou, C.-W., Tu, H., Yu, Y. ‐., Chang, L., & Lai, C. (2013) · European Journal of Pain · doi:10.1002/j.1532-2149.2013.00356.x · Cited by 64
“One-third of diabetic patients have painful neuropathy symptoms and 60% of them have severe neuropathy (Abbott et al., 2011).”
BackgroundGeorge, D., Hackelberg, S., Jayaraj, N. D., Ren, D., Edassery, S. L., Rathwell, C. A., Miller, R. E., Malfait, A., Savas, J. N., Miller, R. J., et al. (2021) · Pain · doi:10.1097/j.pain.0000000000002391 · Cited by 67
Botulinum Toxin Type A for the Treatment of Neuropathic Pain in Neuro-Rehabilitation
Intiso, D., Basciani, M., Santamato, A., Intiso, M. B. D., & Rienzo, F. D. (2015) · Toxins · doi:10.3390/toxins7072454 · Cited by 65
“A third of patients with diabetic sensorimotor polyneuropathy develop PDN, and this disorder is more prevalent in type 2 than in type 1 diabetes [77].”
BackgroundPainful diabetic peripheral neuropathy: Health care costs and complications from 2010 to 2015
Kiyani, M., Yang, Z., Charalambous, L. T., Adil, S. M., Lee, H., Yang, S., Pagadala, P., Parente, B. A., Spratt, S. E., & Lad, S. P. (2020) · Neurology Clinical Practice · doi:10.1212/cpj.0000000000000671 · Cited by 63
Alpha-Lipoic Acid as an Antioxidant Strategy for Managing Neuropathic Pain
Viana, M. D. M., Lauria, P. S. S., de Lima, A. A., Opretzka, L. C. F., Marcelino, H. R., & Villarreal, C. F. (2022) · Antioxidants · doi:10.3390/antiox11122420 · Cited by 68
“A cohort survey showed that approximately 21% of patients with clinical neuropathy present symptoms of NP; this rate increases to 60% in cases of severe neuropathies [11].”
BackgroundMalik, R. A., Aldinc, E., Chan, S.-P., Deerochanawong, C., Hwu, C., Rosales, R. L., Yeung, C., Fujii, K., & Parsons, B. (2017) · Advances in Therapy · doi:10.1007/s12325-017-0536-5 · Cited by 62
Self-citationVitamin D deficiency is associated with painful diabetic neuropathy
Alam, U., Petropoulos, I. N., Ponirakis, G., Ferdousi, M., Asghar, O., Jeziorska, M., Marshall, A. G., Boulton, A. J. M., Efron, N., & Malik, R. A. (2020) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3361 · Cited by 63
Self-citationSendi, R. A., Mahrus, A., Saeed, R. M., Mohammed, M., & Al‐Dubai, S. A. R. (2020) · Journal of Family Medicine and Primary Care · doi:10.4103/jfmpc.jfmpc_927_19 · Cited by 65
Animal models of diabetic microvascular complications: Relevance to clinical features
Singh, R., Farooq, S. A., Mannan, A., Singh, T. G., Najda, A., Zawiślak, G., Albadrani, G. M., Sayed, A. A., & Abdel‐Daim, M. M. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112305 · Cited by 67
Vitamin D and Diabetic Complications: True or False Prophet?
Alam, U., Arul-Devah, V., Javed, S., & Malik, R. A. (2016) · Diabetes Therapy · doi:10.1007/s13300-016-0159-x · Cited by 60
Self-citationPathophysiology and management of diabetic gastroenteropathy
Meldgaard, T., Keller, J., Olesen, A. E., Olesen, S. S., Krogh, K., Borre, M., Farmer, A., Brock, B., Brock, C., & Drewes, A. M. (2019) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756284819852047 · Cited by 56
“, motility dysfunction can lead to sensory symptoms: (1) autonomic neuropathy influencing the parasympathetic (2) and (3) sympathetic pathways.”
BackgroundUpdate on the Management of Diabetic Neuropathy
Ang, L., Cowdin, N., Mizokami-Stout, K., & Pop-Busui, R. (2018) · Diabetes Spectrum · doi:10.2337/ds18-0036 · Cited by 55
Worthington, A., Alam, U., Themistocleous, A. C., Calcutt, N. A., & Marshall, A. G. (2021) · Clinical Therapeutics · doi:10.1016/j.clinthera.2021.03.020 · Cited by 61
Gupta, R., & Misra, A. (2016) · Journal of Diabetes · doi:10.1111/1753-0407.12378 · Cited by 60
Association of Vitamin D Deficiency with Diabetic Nephropathy
Hong, S., Kim, Y. B., Choi, H. S., Jeong, T., Kim, J. T., & Sung, Y. (2021) · Endocrinology and Metabolism · doi:10.3803/enm.2020.826 · Cited by 54
Elliott, D., SLOAN, G. P., Stevens, L. K., Selvarajah, D., Cruccu, G., Gandhi, R. A., Kempler, P., Fuller, J., Chaturvedi, N., Tesfaye, S. H., et al. (2023) · Diabetologia · doi:10.1007/s00125-023-06025-z · Cited by 70
Wherefore Art Thou, O Treatment for Diabetic Neuropathy?
Malik, R. A. (2016) · International review of neurobiology · doi:10.1016/bs.irn.2016.03.008 · Cited by 55
Self-citationAnxiety affects disability and quality of life in patients with painful diabetic neuropathy
Geelen, C. C., Smeets, R. J. E. M., Schmitz, S., van den Bergh, J. P., Goossens, M. E. J. B., & Verbunt, J. A. (2017) · European Journal of Pain · doi:10.1002/ejp.1067 · Cited by 54
“In our study, PDN was associated with a lower QoL (Geelen et al., 2017) and disability (Abbott et al., 2011).”
BackgroundThe H-Reflex as a Biomarker for Spinal Disinhibition in Painful Diabetic Neuropathy
Lee-Kubli, C. A., Marshall, A. G., Malik, R. A., & Calcutt, N. A. (2018) · Current Diabetes Reports · doi:10.1007/s11892-018-0969-5 · Cited by 55
Self-citationZhou, Y., Ying, X., He, X., et al. (2018) · Purinergic Signalling · doi:10.1007/s11302-018-9617-4 · Cited by 54
Diabetic peripheral neuropathy in people with type 2 diabetes: too little too late
Javed, S., Hayat, T., Menon, L., Alam, U., & Malik, R. A. (2019) · Diabetic Medicine · doi:10.1111/dme.14194 · Cited by 65
Self-citationZhang, B., Zhang, Y., Sun, Q., Zhang, P., Wang, X., Xu, G., Hu, J., & Zhang, H. (2020) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13303 · Cited by 56
Cutaneous pain in disorders affecting peripheral nerves
Stucky, C. L., & Mikesell, A. R. (2021) · Neuroscience Letters · doi:10.1016/j.neulet.2021.136233 · Cited by 60
Baskozos, G., Themistocleous, A. C., Hébert, H. L., Pascal, M. M. V., John, J., Callaghan, B. C., Laycock, H. C., Granovsky, Y., Crombez, G., Yarnitsky, D., et al. (2022) · BMC Medical Informatics and Decision Making · doi:10.1186/s12911-022-01890-x · Cited by 61
Alam, U., Fawwad, A., Shaheen, F., Tahir, B., Basit, A., & Malik, R. A. (2017) · Journal of Diabetes Research · doi:10.1155/2017/7928083 · Cited by 53
“Vitamin D deficiency is more prevalent in South Asians [6], even in people living in South Asia including Pakistan [7], and in Pakistan, the prevalence of vitamin D deficiency ranges from 40% [8] to 83% [9].”
BackgroundSelf-citationThe conundrum of diabetic neuropathies—Past, present, and future
Ang, L. P., Mizokami‐Stout, K., Eid, S., Elafros, M. A., Callaghan, B. C., Feldman, E. L., & Pop‐Busui, R. (2022) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2022.108334 · Cited by 66
Elzinga, S. E., Savelieff, M. G., O’Brien, P. D., Mendelson, F. E., Hayes, J. M., & Feldman, E. L. (2021) · Disease Models & Mechanisms · doi:10.1242/dmm.048909 · Cited by 55
Neuroinflammation Involved in Diabetes-Related Pain and Itch
Fang, X.-X., Wang, H., Song, H.-L., Wang, J., & Zhang, Z. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.921612 · Cited by 61
Prevalence and risk factors of painful diabetic neuropathy: A systematic review and meta-analysis
Tao, Y. K., Zhang, H. Y., MacGilchrist, C., Kirwan, E., & McIntosh, C. D. (2025) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2025.112099 · Cited by 76
Li, S., Li, Q., Li, Y., Li, L., Tian, H., & Sun, X. (2015) · PLoS ONE · doi:10.1371/journal.pone.0119479 · Cited by 53
“About one third of diabetic patients suffer from painful neuropathy [13].”
BackgroundLongitudinal patient-oriented outcomes in neuropathy: Importance of early detection and falls
Callaghan, B. C., Kerber, K. A., Langa, K. M., Banerjee, M., Rodgers, A. F., McCammon, R. J., Burke, J. F., & Feldman, E. L. (2015) · Neurology · doi:10.1212/wnl.0000000000001714 · Cited by 55
Fauzi, A., Chung, T. Y., & Latif, L. (2016) · Singapore Medical Journal · doi:10.11622/smedj.2016074 · Cited by 51
Murphy, D., Lester, D. D., Smither, F. C., & Balakhanlou, E. (2020) · Neurorehabilitation · doi:10.3233/nre-208002 · Cited by 61
“A study of diabetics receiving community-based health care in northwest England found that about a third of these individuals had painful neuropathic symptoms (Abbott et al., 2011).”
BackgroundNovel Therapies for the Treatment of Neuropathic Pain: Potential and Pitfalls
Shinu, P., Morsy, M. A., Nair, A. B., Mouslem, A. K. A., Venugopala, K. N., Goyal, M., Bansal, M., Jacob, S., & Deb, P. K. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11113002 · Cited by 61
“Not all individuals with central nervous system injury or peripheral neuropathy tend to develop neuropathic pain [3].”
BackgroundJacovides, A., Bogoshi, M., Distiller, L. A., Mahgoub, E. Y., Omar, M. K., Tarek, I. A., & Wajsbrot, D. (2014) · Journal of International Medical Research · doi:10.1177/0300060514525759 · Cited by 51
“While numerous studies have assessed the prevalence of DPN, many do not report the prevalence ofDPNP.(5) Furthermore, studies show that DPNP is underdiagnosed and undertreated.”
BackgroundResultInfluentialGriggs, R. B., Donahue, R. R., Adkins, B. G., Anderson, K. L., Thibault, O., & Taylor, B. K. (2016) · The Journal of Pain · doi:10.1016/j.jpain.2015.11.006 · Cited by 49
“Pioglitazone normalized pressure thresholds in ZDF [drug; F (1, 17) = 104.”
InfluentialPrevalence and risk factors for painful diabetic neuropathy in secondary healthcare in Qatar
Ponirakis, G., Elhadd, T. A., Chinnaiyan, S., Dabbous, Z., Siddiqui, M., Almuhannadi, H., Petropoulos, I. N., Khan, A., Ashawesh, K., Dukhan, K., et al. (2019) · Journal of Diabetes Investigation · doi:10.1111/jdi.13037 · Cited by 51
Self-citationKoetsier, E., Franken, G., Debets, J., Heijmans, L., van Kuijk, S. M. J., Linderoth, B., Joosten, E. A. J., & Maino, P. (2019) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13192 · Cited by 51
Petersen, E. A., Stauss, T. G., Scowcroft, J. A., Brooks, E. S., White, J. L., Sills, S. M., Amirdelfan, K., Guirguis, M. N., Xu, J., Yu, C., et al. (2022) · Diabetes Care · doi:10.2337/dc21-1813 · Cited by 48
“Approximately 20% of persons with diabetes will develop painful diabetic neuropathy (PDN) with paresthesia, burning, and shooting pain (1).”
BackgroundWhich Test for Diagnosing Early Human Diabetic Neuropathy?
Malik, R. A. (2014) · Diabetes · doi:10.2337/db14-0492 · Cited by 48
Self-citationWin, M. M. T. M., Fukai, K., Nyunt, H. H., Hyodo, Y., & Linn, K. Z. (2019) · Nursing and Health Sciences · doi:10.1111/nhs.12618 · Cited by 49
“As such, our findings were consistent with Abbott et al. (2011).”
ResultUpregulation of miR-133a-3p in the Sciatic Nerve Contributes to Neuropathic Pain Development
Chang, L., Wang, H., Tseng, K., Su, M., Wang, J., Chuang, Y.-T., Wang, Y., & Cheng, K. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-01999-y · Cited by 48
The ocular surface and diabetes, the other 21st Century epidemic
Bu, Y., Shih, K. C., & Tong, L. H. T. (2022) · Experimental Eye Research · doi:10.1016/j.exer.2022.109099 · Cited by 54
Axonopathy in peripheral neuropathies: Mechanisms and therapeutic approaches for regeneration
Landowski, L. M., Dyck, P. J., Engelstad, J. K., & Taylor, B. V. (2016) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2016.04.006 · Cited by 54
Algeffari, M. (2018) · Journal of Family and Community Medicine · doi:10.4103/jfcm.jfcm_145_16 · Cited by 47
Byrne, F., Cheetham, S. C., Vickers, S. P., & Chapman, V. (2015) · Journal of Diabetes Research · doi:10.1155/2015/752481 · Cited by 58
“Neuropathy occurs in 50–60% of patients [3] and pain manifests in around 30% of diabetic patients with neuropathy [4]; symptoms include tingling, burning, spontaneous pain, allodynia, and hyperalgesia.”
BackgroundZhang, Q., Li, Q., Liu, S., Zheng, H., Ji, L., Yi, N., Bao, W., Zhu, X., Sun, W., Liu, X., et al. (2022) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2022.109806 · Cited by 51
Small and large fiber neuropathy in those with type 1 and type 2 diabetes: a 5‐year follow‐up study
Løseth, S., Stålberg, E., Lindal, S., Olsen, E., Jorde, R., & Mellgren, S. I. (2015) · Journal of the Peripheral Nervous System · doi:10.1111/jns.12154 · Cited by 73
“In an epidemiological study the risk of painful neuropathy in type 2 diabetes was reported to be double that found in type 1 (Abbott et al., 2011).”
BackgroundNeuropathic pain in individuals with sickle cell disease
Sharma, D., & Brandow, A. M. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2019.134445 · Cited by 50
Gylfadottir, S. S., Itani, M., Kristensen, A. G., Tankisi, H., Jensen, T. S., Sindrup, S. H., Bennett, D., Nyengaard, J. R., Finnerup, N. B., & Karlsson, P. (2021) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000001111 · Cited by 49
Diabetic peripheral neuropathy and its evaluation in a clinical scenario: A review
Dixit, S., & Maiya, A. G. (2014) · Journal of Postgraduate Medicine · doi:10.4103/0022-3859.128805 · Cited by 49
Duarte, R. V., Andronis, L., Lenders, M. W. P. M., & de Vos, C. C. (2015) · Quality of Life Research · doi:10.1007/s11136-015-1211-4 · Cited by 45
Andersen, S. T., Grosen, K., Tankişi, H., Charles, M., Andersen, N. T., Andersen, H., Petropoulos, I. N., Malik, R. A., Jensen, T. S., & Karlsson, P. (2018) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2018.09.016 · Cited by 46
Self-citationBaba, M., Matsui, N., Kuroha, M., Wasaki, Y., & Ohwada, S. (2019) · Journal of Diabetes Investigation · doi:10.1111/jdi.13178 · Cited by 45
Staniszewska, A., Game, F., Nixon, J., Russell, D., Armstrong, D. G., Ashmore, C., Bus, S. A., Chung, J., Chuter, V., Dhatariya, K., et al. (2024) · Diabetes Care · doi:10.2337/dc24-1112 · Cited by 45
Roderick, P., Turner, V., Readshaw, A., Dogar, O. F., & Siddiqi, K. (2019) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2019.05.035 · Cited by 53
Won, J. C., Kim, S. S., Ko, K. S., & Cha, B. Y. (2014) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2014.38.1.25 · Cited by 48
Kazemi, M., Moghimbeigi, A., Kiani, J., Mahjub, H., & Faradmal, J. (2016) · Epidemiology and Health · doi:10.4178/epih.e2016011 · Cited by 44
“neuropathy, 6≤NDS ≤8 moderate neuropathy,and NDS≥9 severe neuropathy [14].”
BackgroundLi, J., Zhang, W., Wang, X., Yuan, T., Liu, P., Wang, T., Shen, L., Huang, Y., Li, N., You, H., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0190699 · Cited by 48
Yamagata, R., Nemoto, W., Nakagawasai, O., Takahashi, K., & Tan–No, K. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.113825 · Cited by 44
Duarte, R. V., Nevitt, S. J., Maden, M., Meier, K., Taylor, R. S., Eldabe, S. S., & de Vos, C. C. (2021) · Pain · doi:10.1097/j.pain.0000000000002262 · Cited by 69
The Role of Sodium Channels in Painful Diabetic and Idiopathic Neuropathy
On behalf of the PROPANE Study group, Lauria, G., Ziegler, D., Malik, R. A., Merkies, I. S. J., Waxman, S. G., & Faber, C. G. (2014) · Current Diabetes Reports · doi:10.1007/s11892-014-0538-5 · Cited by 46
Self-citationChannelopathies, painful neuropathy, and diabetes: which way does the causal arrow point?
Hoeijmakers, J. G. J., Faber, C. G., Merkies, I. S. J., & Waxman, S. G. (2014) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2014.06.003 · Cited by 44
Cheng, R.-X., Feng, Y. Y., Liu, D., Wang, Z., Zhang, J., Chen, L., Su, C., Wang, B., Huang, Y., Ji, R., et al. (2019) · Theranostics · doi:10.7150/thno.36077 · Cited by 46
Ponirakis, G., Elhadd, T. A., Chinnaiyan, S., Hamza, A. H., Sheik, S., Kalathingal, M. A., Anodiyil, M. S., Dabbous, Z., Siddique, M. A., Almuhannadi, H., et al. (2020) · Journal of Diabetes Investigation · doi:10.1111/jdi.13388 · Cited by 44
Self-citationKarlsson, P., Provitera, V., Caporaso, G., Stancanelli, A., Saltalamacchia, A. M., Borreca, I., Manganelli, F., Santoro, L., Jensen, T. S., & Nolano, M. (2020) · Pain · doi:10.1097/j.pain.0000000000002054 · Cited by 46
Croosu, S. S., Røikjer, J., Mørch, C. D., Ejskjær, N., Frøkjær, J. B., & Hansen, T. M. (2022) · Diabetes Care · doi:10.2337/dc22-0587 · Cited by 42
Excitatory and inhibitory neuronal signaling in inflammatory and diabetic neuropathic pain
Breitinger, U., & Breitinger, H. (2023) · Molecular Medicine · doi:10.1186/s10020-023-00647-0 · Cited by 46
Razazian, N., Baziyar, M., Moradian, N., Afshari, D., Bostani, A., & Mahmoodi, M. (2014) · Neurosciences · doi:10.17712/1658-3183.2082 · Cited by 43
Surgical Decompression of Painful Diabetic Peripheral Neuropathy: The Role of Pain Distribution
Liao, C., Zhang, W., Yang, M., Ma, Q., Li, G., & Zhong, W. (2014) · PLoS ONE · doi:10.1371/journal.pone.0109827 · Cited by 42
“[5] One-third of diabetic patients have symptoms of neuropathic pain according to a recent community-based study [6] and up to 15–20% of patients with DPN may experience painful symptoms.”
BackgroundDurán, A. M., Salto, L., Camara, J. R., Basu, A., Perez‐Paquien, I., Beeson, W. L., Firek, A. F., Cordero‐MacIntyre, Z., & León, M. A. D. (2019) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s187268 · Cited by 45
“23 These findings suggest that interventions that reverse lipotoxicity-mediated metabolic stress and reduce sphingolipid-mediated apoptosis may be potential therapeutic targets to address painful DN. Omega-3 PUFAs are known to protect tissue from lipotoxicity-induced metabolic stress.”
InfluentialStructure–function relationships in peripheral nerve contributions to diabetic peripheral neuropathy
Frank, T., Nawroth, P. P., & Kuner, R. (2019) · Pain · doi:10.1097/j.pain.0000000000001530 · Cited by 43
A study of diabetes complications in an endogamous population: An emerging public health burden
Bener, A., AL-Laftah, F. A. W., Al-Hamaq, A. O. A. A., Daghash, M., & Abdullatef, W. K. (2014) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2014.04.005 · Cited by 41
An update on the diagnosis and treatment of diabetic somatic and autonomic neuropathy
Azmi, S., Petropoulos, I. N., Ferdousi, M., Ponirakis, G., Alam, U., & Malik, R. A. (2019) · F1000Research · doi:10.12688/f1000research.17118.1 · Cited by 49
“Estimates of the prevalence of PDPN range from 14.0 to 65.3% 61,64–69 (Figure 1).”
BackgroundInfluentialSelf-citationPerkins, B. A., Bril, V., & Izenberg, A. (2015) · Seminars in Neurology · doi:10.1055/s-0035-1558972 · Cited by 46
Nutmeg Extracts for Painful Diabetic Neuropathy: A Randomized, Double-Blind, Controlled Study
Motilal, S., & Maharaj, R. G. (2012) · The Journal of Alternative and Complementary Medicine · doi:10.1089/acm.2012.0016 · Cited by 45
Li, S., Brimmers, A., van Boekel, R. L. M., Vissers, K. C. P., & Coenen, M. J. H. (2023) · Pain · doi:10.1097/j.pain.0000000000002910 · Cited by 49
Huffman, C., Stacey, B. R., Tuchman, M., Burbridge, C., Li, C., Parsons, B., Pauer, L., Scavone, J. M., Behar, R., & Yurkewicz, L. (2015) · The Clinical Journal of Pain · doi:10.1097/ajp.0000000000000198 · Cited by 37
Metadata
- Authors
- Abbott, C. A., Malik, R. A., van Ross, E. R. E., Kulkarni, J., & Boulton, A. J. M.
- Affiliations
- University of Manchester (GB)
- Disablement Services Centre, Withington Hospital, Manchester, U.K.
- Withington Community Hospital (GB)
- Corresponding author
- Abbott, Caroline A.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2011-09-15
- Volume
- 34
- Issue
- 10
- Pages
- 2220-2224
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC3177727
- OpenAlex
- W2162902338
- Semantic Scholar
- f503e4898de5486de267534e888652f729e9319c
- Cited by
- 868
- References
- 19
- Citations by year
- 2026: 38 · 2025: 67 · 2024: 74 · 2023: 69 · 2022: 70 · 2021: 97 · 2020: 99 · 2019: 64 · 2018: 54 · 2017: 48 · 2016: 47 · 2015: 52 · 2014: 41 · 2013: 35 · 2012: 12
- FWCI
- 19.19
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-nd
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Research Explorer (The University of Manchester) (publishedVersion)
- e-space (Manchester Metropolitan University) (acceptedVersion)
- Research Explorer (The University of Manchester) (submittedVersion)
- Funders
- American Diabetes Association
- National Institute for Health and Care Research
- Topics
- Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
- Health Sciences › Medicine › Clinical Neurology › Peripheral Neuropathies and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetic Foot Ulcer Assessment and Management
- Keywords
- diabetic neuropathic pain, prevalence, type 2 diabetes, type 1 diabetes, sex differences, ethnicity, South Asians, neuropathy severity, neuropathic pain, neuropathy screening
- MeSH terms
- Administration, Oral, Adult, Aged, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Diabetic Neuropathies, Female, United Kingdom, Humans, Hypoglycemic Agents, Male, Middle Aged, Sex Factors, Age Distribution
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
